Data / Form D filings / CELLULAR BIOENGINEERING INC
CELLULAR BIOENGINEERING INC: Form D filing
CELLULAR BIOENGINEERING INC, a biotechnology company in Honolulu, HI, filed a Form D with the SEC in 2014. The latest, on January 27, 2014, reports $2 million sold of a $4 million offering to 2 investors.
Find out what CELLULAR BIOENGINEERING INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 650 Iwilei Road, Suite 290, Honolulu, HI, 96817
- Phone
- (808) 949-2208
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1254979
The full lists. Form D filings in Hawaii: 59 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 27, 2014 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 2 | Jun 3, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hank C.K. Wuh | Executive Officer, Director | |
| Jeffrey R. Watanabe | Director | |
| Ellary C.K. Kim | Executive Officer | |
| George R. Ariyoshi | Director |
Every Form D from the week of Jan 27, 2014 · All recent filings in Hawaii · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CELLULAR BIOENGINEERING INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.